|
|
|
|
|
Product Name
|
Factor XIa protein
|
|
Product type
|
Proteins and Peptides
|
|
Peptide
|
Full length native Factor XIa protein (purified) (Human).
|
|
Tested applications
(see key)
|
FuncS, SDS-PAGE
|
|
Application notes
(see key)
|
Recommended dilutions Activity was determined in a clotting assay using factor XI deficient plasma: Use at an assay dependent dilution. SDS-PAGE: Use at an assay dependent dilution.
Not yet tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
|
|
Research areas
|
Cardiovascular >> Blood >> Coagulation >> Intrinsic
|
|
Relevance
|
Proteolysis of XI by factor XIIa in the presence of high molecular weight kininogen (HMWK), yields the enzyme factor XIa. Factor XIa is a serine protease which participates in the intrinsic pathway of coagulation by catalyzing the conversion of factor IX to factor IXa. Because factor XI is a homodimer, the enzyme, factor XIa, is composed of two identical heavy chains (MW 50kDa), and two identical light chains (MW 30kDa), all of which are held together by disulfide bonds. This latter property makes factor XIa unique among the serine proteases, since it contains two active sites per molecule. Factor XIa, like its precursor factor XI, remains in complex with HMWK. In complex form, factor XIa/HMWK is capable of activating factor XII to factor XIIa and prekallikrein to kallikrein. Additionally, in the complexed form, factor XIa is less affected by protease inhibitors. The major plasma inhibitor of factor XIa is a1-antitrypsin and then to a much lesser extent, antithrombin-III. While in the complexed form, factor XIa may catalyze the proteolysis of HMWK, yielding a biologically inactive form of HMWK (HMWKi), thus allowing dissociation of the Factor XIa/HMWKi complex. Either free factor XIa or the factor XIa/HMWK complex catalyzes the proteolytic conversion of factor IX to factor IXa.
|
|
|
Factor XIa protein (ab62411)
|
|
Storage buffer
|
Preservative: None Constituents: 50% Glycerol, 50% H2O Material safety datasheet (MSDS) for this product: Glycerol MSDS
|
|
Purification notes
|
Factor XIa was prepared by activating purified factor XI with factor XIIa. Following activation, the mixture is passed over a column of immobilized anti-factor XII to remove the factor XIIa, and further purified on heparin-Sepharose. Purity is assessed by SDS PAGE analysis.
|
|
Form
|
Liquid
|
|
Concentration
|
4.500 mg/ml
|
|
Storage instructions
|
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
|
| |
At Abcam, we have one centralized database to hold all of our product information, so that everything we know about this Factor XIa protein is on this datasheet. But please do contact us if you would like any reassurance! |
 |
|
| |
|
Search PubMed (MEDLINE) for references to Factor XIa
|
| |
Factor XIa protein - more information
|
Customer reviews (feedback) regarding Factor XIa protein |
Customer FAQs regarding Factor XIa protein |
Protocols for Factor XIa protein |
Price and availability of products related to Factor XIa protein |
| |
Factor XIa protein - other tools:
|
Contact Abcam with a Technical Enquiry about Factor XIa protein |
| |
All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"